FindTrial
Sign In

Radiotherapy followed by chemotherapy

BEHAVIORAL5 trials

Sponsors

Fudan University, Chinese Academy of Medical Sciences, M.D. Anderson Cancer Center, Trans Tasman Radiation Oncology Group, Sohag University

Conditions

Bladder Cancer (BC)Carcinoma, Non-Small-Cell Lung (NSCLC)Extranodal NK/T-cell Lymphoma, Nasal TypeExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeOrodental Injury

Phase 2

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
NCT01667302
Fudan UniversityExtranodal NK/T-cell Lymphoma, Nasal Type
Start: 2012-06-30End: 2016-12-31Target: 30Updated: 2013-03-05
Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
NCT02560441
Chinese Academy of Medical SciencesExtranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Start: 2015-09-30Updated: 2018-01-03

Phase 3

Primary Radiotherapy In MEtastatic Lung Cancer
Not yet recruitingNCT07135882
Trans Tasman Radiation Oncology GroupCarcinoma, Non-Small-Cell Lung (NSCLC)
Start: 2026-08-25End: 2036-12-31Target: 420Updated: 2026-07-31

Unknown Phase

Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
RecruitingNCT06586892
M.D. Anderson Cancer CenterOrodental Injury
Start: 2025-09-15End: 2032-12-30Target: 300Updated: 2026-08-14
Outcomes of Definitive Radiotherapy for Bladder Cancer
Not yet recruitingNCT07503795
Sohag UniversityBladder Cancer (BC)
Start: 2026-04-01End: 2027-06-01Target: 300Updated: 2026-03-31

Related Papers

Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T‐cell lymphoma patients
Cancer Medicine2020-06-095 citations